CoreAge Rx vs Velvet Rx

The verdict for women

CoreAge Rx edges out Velvet Rx on the Metabolic-Fit Score, 92 to 34 (A− vs C). Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.

Velvet Rx is still a genuine option — velvet Rx publishes three prices and almost nothing else, and the gap between those two facts is the review. The prices are real and stated plainly on its homepage: injectable semaglutide as low as $139 a month, injectable tirzepatide as low as $179, and an oral GLP-1 as low as $189 — which puts it in the cheaper half of this page and makes it one of the few providers here offering an oral formulation alongside the injections. The problem is the phrase 'as low as', which appears on all three and is never resolved. There is no dose ladder, no plan length, no billing cadence, and no pricing page at all: /pricing and /weight-loss both return 404, and the homepage is the only page on the site carrying a number. So $139 is a floor, and nothing published tells you how far above it a maintenance dose sits. The disclosure gaps compound from there. No compounding pharmacy is named, no clinician is named, coverage is not stated, and its own cancellation FAQ asks 'How do cancellations and refunds work?' and answers with 'our care team will guide you with personalized support' — which is not an answer. The operating entity is Rocket Health Inc.; neither the brand nor that entity has an FDA warning letter. Treat the $139 as an opening bid rather than a price. Weigh the six women's-health factors below against your own priorities.